WCA
BIO icon

Waratah Capital Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Waratah Capital Advisors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,271
Closed -$440K – 125
2024
Q1 		$440K Buy
+1,271
New +$418K 0.02% 141
2022
Q4 		– Sell
-5,524
Closed -$2.3M – 197
2022
Q3 		$2.3M Buy
5,524
+320
+6% +$160K 0.15% 117
2022
Q2 		$2.57M Buy
5,204
+3,429
+193% +$1.79M 0.14% 111
2022
Q1 		$1M Buy
+1,775
New +$1.07M 0.05% 154

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $18.8B AUM 17.33% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return